tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports

NervGen Pharma (NGEN) Income Statement

84 Followers

NervGen Pharma Income Statement

Last quarter (Q3 2025), NervGen Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NervGen Pharma's net income was $-2.98M. See NervGen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Dec 22Dec 21Mar 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -58.23K$ -109.40K$ -84.92K$ -33.70K$ -31.12K
Operating Expenses
$ 17.27M$ 13.30M$ 16.90M$ 10.09M$ 8.76M
Depreciation and Amortization
$ 58.23K$ 109.40K$ 84.92K$ 33.70K$ 31.12K
EBITDA
$ -16.62M$ -16.78M$ -14.82M$ -10.03M$ -8.75M
Operating Income
$ -17.33M$ -13.41M$ -16.99M$ -10.13M$ -8.79M
Other Income/Expenses
$ 643.55K$ -3.47M$ 1.70M$ 66.92K$ 7.65K
Pretax Income
$ -16.68M$ -16.89M$ -15.29M$ -10.06M$ -8.78M
Net Income
$ -16.68M$ -16.89M$ -15.29M$ -10.06M$ -8.78M
Per Share Metrics
Basic EPS
$ -0.25$ -0.28$ -0.29$ -0.26$ -0.27
Diluted EPS
$ -0.25$ -0.28$ -0.29$ -0.26$ -0.27
Weighted Average Shares Outstanding
 67.32M 59.29M 52.65M 39.29M 32.11M
Weighted Average Shares Outstanding (Diluted)
 67.32M 59.29M 52.65M 39.29M 32.11M
Currency in USD

NervGen Pharma Earnings and Revenue History